Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effectBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
The Journal of Antimicrobial Chemotherapy|January 28, 2026
Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar ratsHitesh A Kadu, Viral I Rajwadi, Jigar V Shah, et al.
Chemico-Biological Interactions|May 11, 2026
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar ratsPraveen Kumar Jain, Laxit K Bhatt, Ashvin K Patel, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Clinical Pharmacokinetics|May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy VolunteersKevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Chemmedchem|December 16, 2014
Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitorsJayendra Z Patel, Tapio J Nevalainen, Juha R Savinainen, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazoleBrijesh Kumar Srivastava, Rina Soni, Amit Joharapurkar, et al.
Vaccines|September 27, 2025
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of HypercholesterolemiaSuresh R Giri, Akshyaya Chandan Rath, Chitrang J Trivedi, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Pageof 10